1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Ivacaftor + tezacaftor
Trade Name:
Symdeko
Manufacturer/Distributor:
Vertex Pharmaceuticals
Classification:
Cystic Fibrosis Transmembrane Conductance Regulator Correctors and Potentiators
ATC Class:
R07AX31 - ivacaftor + tezacaftor
Status:
active
Notice of Compliance (yyyy/mm/dd):
2018/06/27
Date Marketed in Canada (yyyy/mm/dd):
2018/06/27
Presentation:
Tablet: 150 mg ivacaftor plus 100 mg tezacaftor. Tablet: 150 mg ivacaftor. DIN: 02478080
Comments:
For treatment of patients with cystic fibrosis aged 12 years and older with mutation in the CFTR gene. Dose is fixed dose regimen (150 mg/100 mg) in the morning and 150 mg ivacaftor in the evening.
Source:
Product monograph
Back to:
Drug Product Listings 
